LLY
Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30P/E Ratio · Metrics
P/E Ratio
37.77
PEG Ratio
0.24
Dividend Yield
-
Gross Margin
85.78%
Net Margin
30.88%
Revenue CAGR 3Y
40.34%
ROE
83.77%
ROA
19.95%
Buyback Yield
0.25%
Current Ratio
1.35
Magic Earn Yield
-
Altman Z-Score
-
Fair Value River
Score
Valuation 58
Profitability 82
Growth 100
Health 45
Yield 4